history of glp 1 agonists GLP-1 Market Report 2025-2033, By Product, Molecule, and Geo Addressing patient concerns about the
Description
430 GLP-1RAs and PD PD is a chronic neurodegenerative disorder that affects the CNS and is the second most prevalent neurodegenerative disease worldwide

We are not aware of similar reports in patients treated by GLP1RAs

2024;8:bvad165

We didnt know that GLP-1 would reduce heart attacks and strokes and improve metabolic liver disease and all of the things that GLP-1 does now. Today, millions of people have prescriptions for GLP-1 medications like Ozempic
Adjudicated four-component major adverse cardiovascular event (MACE-4 events

doi: 10.1056/NEJMoa2312323 [DOI] [PubMed] [Google Scholar] 134.Horvth K, Aschermann Z, cs P, et al
